Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 0 $ 0
Operating Expenses    
General And Administrative 1,913,564 1,782,860
Research And Development 262,823 369,450
Total Operating Expenses 2,176,387 2,152,310
Other Operating Income    
Contributed Services - Research And Development 123,353 103,319
Total Other Operating Income 123,353 103,319
Total Operating Loss (2,053,034) (2,048,991)
Other Income    
Interest Income 3,505 3,309
Foreign Currency Transaction Gain 0 33,694
Total Other Income 3,505 37,003
Net Loss Before Income Taxes (2,049,529) (2,011,988)
Income Taxes 0 0
Net Loss (2,049,529) (2,011,988)
Accumulated Preferred Stock Dividend 0 (131,434)
Additional Deemed Dividend On Preferred Stock Due To The Beneficial Conversion Feature 0 (57,489)
Net Loss Attributable To Common Shareholders $ (2,049,529) $ (2,200,911)
Net Loss Per Common Share    
Basic And Diluted $ (0.20) $ (0.33)
Weighted Average Number Of Common Shares Outstanding - Basic And Diluted 10,283,280 6,589,392